These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9164568)

  • 21. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
    Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
    J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
    Dolan SB; Forster MJ; Gatch MB
    Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the role of catecholamines in the response to various central stimulants.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonazepam prevents the development of sensitization to methamphetamine.
    Ito K; Ohmori T; Abekawa T; Koyama T
    Pharmacol Biochem Behav; 1997 Dec; 58(4):875-9. PubMed ID: 9408189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the behavioural responses induced by chronic administration of methamphetamine and amphetamine in mice.
    Peachey JE; Rogers B; Brien JF
    Psychopharmacology (Berl); 1977 Jan; 51(2):137-40. PubMed ID: 402664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
    Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
    Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F; O'Halloran A; Kelly JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are the effects of psychomotor stimulant drugs on hyperactive children really paradoxical?
    Sahakian BJ; Robbins TW
    Med Hypotheses; 1977; 3(4):154-8. PubMed ID: 19688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.
    Milesi-Hallé A; McMillan DE; Laurenzana EM; Byrnes-Blake KA; Owens SM
    Pharmacol Biochem Behav; 2007 Jan; 86(1):140-9. PubMed ID: 17275894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization.
    Janetsian SS; Linsenbardt DN; Lapish CC
    Psychopharmacology (Berl); 2015 Jun; 232(12):2083-95. PubMed ID: 25572530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1994 Dec; 666(1):147-50. PubMed ID: 7534194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenytoin potentiates methamphetamine-induced behavior in mice.
    Izumi K; Nomoto M; Koja T; Shimizu T; Kishita C; Fukuda T
    Pharmacol Biochem Behav; 1984 May; 20(5):803-6. PubMed ID: 6539921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The absence of impairment of cliff avoidance reaction induced by subchronic methamphetamine treatment in inbred strains of mice.
    Yoshida S; Numachi Y; Matsuoka H; Sato M
    Tohoku J Exp Med; 2000 Mar; 190(3):205-12. PubMed ID: 10778804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in the behavioral effects of methamphetamine.
    Schindler CW; Bross JG; Thorndike EB
    Eur J Pharmacol; 2002 May; 442(3):231-5. PubMed ID: 12065076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methcathinone: a new and potent amphetamine-like agent.
    Glennon RA; Yousif M; Naiman N; Kalix P
    Pharmacol Biochem Behav; 1987 Mar; 26(3):547-51. PubMed ID: 3575369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy.
    Hashimoto A; Konno R; Yano H; Yoshikawa M; Tamaki R; Matsumoto H; Kobayashi H
    Eur J Pharmacol; 2008 May; 586(1-3):221-5. PubMed ID: 18448092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.